Navigation Links
Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
Date:7/2/2012

SEATTLE, July 2, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that it has closed the underwritten public offering that was priced and allocated to investors prior to the opening of the market on June 27, 2012, relating to the sale of 3,365,854 shares of its common stock at a price of $10.25 per share for gross proceeds of approximately $34.5 million. The closing included the sale of 439,024 shares of common stock sold pursuant to the overallotment option granted by Omeros to the underwriters, which the underwriters exercised in full. After deducting underwriting discounts and other estimated offering expenses, Omeros will receive net proceeds from the transaction of approximately $32.3 million.

Omeros intends to use the net proceeds of the offering for general corporate purposes, including expenses related to the clinical development of Omeros' two ongoing Phase 3 clinical development programs – OMS302 for use during intraocular lens replacement procedures and OMS103HP for use during arthroscopic partial meniscectomy surgery. The net offering proceeds may also be used to fund research and development in Omeros' preclinical studies and clinical trials, capital expenditures, working capital and to otherwise advance Omeros' product candidates toward commercialization.

Cowen and Company, LLC and Deutsche Bank Securities Inc. acted as the joint book-running managers for the offering, Canaccord Genuity Inc. and Wedbush PacGrow Life Sciences acted as co-managers, and WBB Securities served as a financial advisor to Omeros.

A shelf registration statement (File No. 333-169856) relating to these securities was filed with the Securities and Exchange Commission on October 8, 2010 and declared effective on October 18, 2010. A final prospectus supplement related to the offering was filed with the Securities and Exchange Commission on
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omeros Prices $30 Million Public Offering of Common Stock
2. Omeros Announces Proposed Public Offering of Common Stock
3. Omeros to Present at Jefferies 2012 Global Healthcare Conference
4. Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
5. Omeros to Present at Deutsche Bank Securities Health Care Conference
6. Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company
7. MicroVention Announces First Patient Enrollment In Clinical Trial To Compare Coiling Technologies For Treating Brain Aneurysms
8. Omron Healthcare Announces New Pedometers
9. Improved Maintenance and Control of Electronic Health Records. ICAP Patent Brokerage Announces for Auction Patented Techniques for Improved Patient Control and Selective Access to Electronic Medical Records
10. Lilly Diabetes Announces Once Upon A Time Contest Winner
11. Roche announces FDA approval of HIV viral load test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 05, 2015 Research and Markets ... "Will Theranos Turn the Lab Industry Upside Down?" ... received much praise along with a healthy dose of ... with their potentially disruptive laboratory solution. Behind all of ... Has Theranos scaled microfluidic technology across a comprehensive menu ...
(Date:5/5/2015)... 2015 - No one has ... like us: ABMRG - Primary research covering ... Comparative analysis among states & regions; hospital chains; govt. ... The coronary stent market in India ... Metal Stent (BMS) and Bio-Absorbable Stent (BVS), was valued ...
(Date:5/5/2015)... VANCOUVER, British Columbia , May 5, 2015 ... IMLFF), a clinical stage biopharmaceutical company that specializes ... today that former GW Pharmaceuticals financier, investor, and ... to support InMed as Strategic Advisor with primary ... In this role, Mr. Mountford will leverage his ...
Breaking Medicine Technology:Will Theranos Turn the Lab Industry Upside Down? 2India Coronary Stent Market to be Tripled by 2021 2India Coronary Stent Market to be Tripled by 2021 3India Coronary Stent Market to be Tripled by 2021 4InMed Engages Peter Mountford as Strategic Advisor 2InMed Engages Peter Mountford as Strategic Advisor 3InMed Engages Peter Mountford as Strategic Advisor 4
... on complex cases, facility called ,future of hospital care, ... announces the opening of the Hamon Tower, the largest expansion ... intensive care for the region,s most critically ill patients. , ... new clinical programs for ICU patients, Hamon Tower is designed ...
... IRVINE, Calif., Oct. 2 ISTA Pharmaceuticals, Inc. (Nasdaq: ... financial results after market close on November 3, 2009. In ... p.m. Eastern Time to discuss these results and provide a ... , Time: 5:00 p.m. Eastern Time , Conference call ...
Cached Medicine Technology:Hamon Tower Features Critical Care Advances, Potential for Reduced Costs 2
(Date:5/5/2015)... Crawford Technologies announced today it has been ... Chapter of the Business Marketing Association (BMA) for the ... Award was presented to the CrawfordTech marketing team on Friday, ... with over 300 people in attendance. , “The launch of ... represented a shift in focus for how our company communicates ...
(Date:5/5/2015)... Every year, news articles appear warning about ... worst dry eye season is spring, also known as allergy ... the United States. The only season offering a respite from ... host of the Sharon Kleyne Hour™ Power of Water® radio ... of May 11, 2015. Kleyne is the inventor of Nature’s ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 After conducting ... leadership solutions firm B. E. Smith, West Holt ... Pfeifer as chief executive officer. A skilled healthcare executive ... will assume his new duties on June 1st. , ... as well as a keen understanding and success in ...
(Date:5/5/2015)... LENEXA, Kan. (PRWEB) May 05, 2015 ... dedicated exclusively to healthcare providers, has been retained to ... Hospital in Helena, Mont. The top executive search firm ... placed more than 900 healthcare executives into organizations. , ... psychiatric treatment facility in Montana to offer both acute ...
(Date:5/5/2015)... Dealing with injuries and medical expenses following ... Personal injury lawyers are excellent resources for accident victims throughout ... their latest article , the Jones Firm gives the top ... a personal injury lawyer to handle their case. , Working ... waste of time if the lawyer does not have a ...
Breaking Medicine News(10 mins):Health News:Crawford Technologies Awarded BMA’s ‘2015 Gold Key Award’ for Innovative Website Redesign 2Health News:Crawford Technologies Awarded BMA’s ‘2015 Gold Key Award’ for Innovative Website Redesign 3Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 2Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 3Health News:West Holt Medical Services Hires New Chief Executive Officer 2Health News:West Holt Medical Services Hires New Chief Executive Officer 3Health News:Shodair Children’s Hospital Retains B. E. Smith to Recruit New Administrator 2Health News:Shodair Children’s Hospital Retains B. E. Smith to Recruit New Administrator 3Health News:5 Top Qualifications for Personal Injury Lawyer Disclosed in Latest Article by The Jones Firm 2
... children of a lesser God. The physical, mental, moral ... One stumbling handicap in the surgical treatment of such ... children. In many cases the anesthesia times ranged from ... placement to hemispherectomy. There is however light at ...
... In India Kidney Stones are not uncommon problem due to the ... up of Calcium, Oxalate and phosphates. The cause of stone disease ... water is a risk factor for stone disease. , ... is a tiny bacteria called Nano bacteria., ,These bacteria ...
... is often difficult to diagnose and many a times ... reaction (PCR) is emerging as a promising technique for ... of bacteria by facilitating rapid amplification of small amounts ... the Millennium International Urology Congress in India. Presence ...
... Transdermal hormone replacement therapy (HRT) does not ... postmenopausal women with existing ,coronary artery disease ... ,Atherosclerosis Study), researchers randomized 255 ,postmenopausal women ... receive either transdermal HRT--17-beta-estradiol ,with or without ...
... way for the survival of endangered animal species of the ... who engineered the feat has managed to clone cells from ... cow with the clone. , ,The scientific journal Cloning ... is expected to deliver the cloned Asian gaur sometime ...
... to have said that more than two-thirds of births in ... from a maternity clinic is suffering health problems. , ... 1992 to just 30 percent last year, said Olga Frolova, ... Science. She thinks that the decline is due to the ...
Cached Medicine News:
Microwell EIA for the detection of EPO (Erythropoietin)...
Microwell EIA for detection of Calcitonin...
... PREMIUM SURGICLIP II™ single ... Titanium Super Interlock™ clips., ... clip applier has application in ... to occlude vessels and other ...
... clip applier consists of an applier shaft with ... 20 titanium clips. , ,The clip applier ... tubular structure. As the handles of the applier ... the vessel or structure. As the handles are ...
Medicine Products: